Back to GAMCO INVESTORS, INC. ET AL GAMCO INVESTORS, INC. ET AL

LFCRLFCR
21 quarters

Position history for GAMCO INVESTORS, INC. ET ALGAMCO INVESTORS, INC. ET AL's holdings in LIFECORE BIOMEDICAL INC

GAMCO INVESTORS, INC. ET AL holds 83,800 shares of LFCR (LIFECORE BIOMEDICAL INC), worth $439,950 as of 2026-Q2. LFCR represents 0.0% of GAMCO INVESTORS, INC. ET AL's portfolio.

Current Value

$439,950

Current Shares

83,800

Total Value Change

-$83,050

Total Shares Change

+37,300

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
83,800
0.0%
$439,9500.0%$5.25
0
2026-Q1
Unchanged
83,800
0.0%
$311,7360.0%$6.99
0
2025-Q4
Decreased
83,800
-0.8%
$685,4840.0%$8.09
0
2025-Q3
Unchanged
84,500
0.0%
$621,9200.0%$7.15
0
2025-Q2
Unchanged
84,500
0.0%
$686,1400.0%$8.19
0
2025-Q1
Decreased
84,500
-1.7%
$594,8800.0%$6.85
0
2024-Q4
Decreased
86,000
-1.7%
$638,9800.0%$7.42
0
2024-Q3
Increased
87,500
+7.8%
$431,3750.0%$4.95
26
2024-Q2
Increased
81,200
+6.6%
$416,5560.0%$5.13
25
2024-Q1
Decreased
76,200
-0.4%
$404,6220.0%$5.31
0
2023-Q4
Unchanged
76,500
0.0%
$473,5350.0%$6.19
0
2023-Q3
Unchanged
76,500
0.0%
$577,1930.0%$7.55
0
2023-Q2
Decreased
76,500
-7.8%
$739,7550.0%$9.84
0
2023-Q1
Decreased
83,000
-4.6%
$313,3250.0%$3.79
0
2022-Q4
Increased
87,000
+10.1%
$563,7600.0%$6.48
27
2022-Q3
Increased
79,000
+2.6%
$702,0000.0%$8.89
25
2022-Q2
Increased
77,000
+2.7%
$768,0000.0%$10.06
25
2022-Q1
Increased
75,000
+2.7%
$869,0000.0%$11.42
26
2021-Q4
Increased
73,000
+23.6%
$810,0000.0%$11.03
30
2021-Q3
Increased
59,082
+27.1%
$545,0000.0%$10.28
30
2021-Q2
New
46,500
-
$523,0000.0%$10.95
33

Other major holders of LFCR: BNP PARIBAS FINANCIAL MARKETS, Russell Investments Group, Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used